BCL2L11 and diabetic kidney disease: Our results provide the first direct evidence that an alteration in the acetylation of a transcription factor (Foxo4) in the podocyte promotes the transcription of a pro-apoptotic gene, Bcl2l11 and contributes to podocyte loss, which is considered a key mechanism of diabetic nephropathy.